A Phase II Trial of 177 Lutetium DOTATATE in Children with Primary Refractory or Relapsed High Risk Neuroblastoma -LUDO

Project Details

Short titleA Phase II Trial of 177 Lutetium DOTATATE in Children with Primary Refractory or Relapsed High Risk Neuroblastoma -LUDO
StatusFinished
Effective start/end date1/04/1330/09/18

Funding

  • Cancer Research UK